Autologous CD22 CAR-T cells

CD22-directed CAR-T cells · Stanford University

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Autologous CD22 CAR-T cells, covering 2025-08-07 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies [Phase 1]